Hazlett, Burt & Watson, Inc. Novartis Ag Transaction History
Hazlett, Burt & Watson, Inc.
- $217 Million
- Q3 2024
A detailed history of Hazlett, Burt & Watson, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 2,059 shares of NVS stock, worth $205,838. This represents 0.11% of its overall portfolio holdings.
Number of Shares
2,059
Previous 2,059
-0.0%
Holding current value
$205,838
Previous $218,000
8.72%
% of portfolio
0.11%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,423Shares Held
130MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.22 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.2 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$809 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$698 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$577 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $215B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...